Report Tools

OTC Pharmaceuticals in Russia

Published: August 2013 · Publisher: MarketLine
OTC Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017).
Report Type Industry Profiles
Language English
Format Electronic (PDF)
Pages33
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-7500
Price € 259,00
Options
  • Description
  • Companies Mentioned
  • Table of Contents
  • Ask a Question
Introduction

OTC Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Russia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.

*The Russian OTC pharmaceuticals market had total revenues of $6,373.7m in 2012, representing a compound annual growth rate (CAGR) of 10% between 2008 and 2012.

*The cough and cold preparations segment was the market's most lucrative in 2012, with total revenues of $1,580.6m, equivalent to 24.8% of the market's overall value

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 7.4% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $9,105.6m by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Russia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Russia

Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Russia otc pharmaceuticals market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Russia economy

Key Questions Answered

What was the size of the Russia otc pharmaceuticals market by value in 2012?

What will be the size of the Russia otc pharmaceuticals market in 2017?

What factors are affecting the strength of competition in the Russia otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Russia's otc pharmaceuticals market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
JSC ELFA, Menarini Group, Pharmstandard OJSC and Sanofi
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
JSC ELFA 20
Menarini Group 21
Pharmstandard OJSC 22
Sanofi 25
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related research 32

LIST OF TABLES
Table 1: Russia OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: Russia OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: Russia OTC pharmaceuticals market geography segmentation: $ million, 2012 10
Table 4: Russia OTC pharmaceuticals market share: % share, by value, 2012 11
Table 5: Russia OTC pharmaceuticals market distribution: % share, by value, 2012 12
Table 6: Russia OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Table 7: JSC ELFA: key facts 20
Table 8: Menarini Group: key facts 21
Table 9: Pharmstandard OJSC: key facts 22
Table 10: Pharmstandard OJSC: key financials ($) 22
Table 11: Pharmstandard OJSC: key financials (RUB) 23
Table 12: Pharmstandard OJSC: key financial ratios 23
Table 13: Sanofi: key facts 25
Table 14: Sanofi: key financials ($) 26
Table 15: Sanofi: key financials (€) 26
Table 16: Sanofi: key financial ratios 27
Table 17: Russia size of population (million), 2008–12 29
Table 18: Russia gdp (constant 2000 prices, $ billion), 2008–12 29
Table 19: Russia gdp (current prices, $ billion), 2008–12 29
Table 20: Russia inflation, 2008–12 30
Table 21: Russia consumer price index (absolute), 2008–12 30
Table 22: Russia exchange rate, 2008–12 30

LIST OF FIGURES
Figure 1: Russia OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2012 10
Figure 4: Russia OTC pharmaceuticals market share: % share, by value, 2012 11
Figure 5: Russia OTC pharmaceuticals market distribution: % share, by value, 2012 12
Figure 6: Russia OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Russia, 2012 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2012 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2012 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2012 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2012 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2012 19
Figure 13: Pharmstandard OJSC: revenues & profitability 23
Figure 14: Pharmstandard OJSC: assets & liabilities 24
Figure 15: Sanofi: revenues & profitability 27
Figure 16: Sanofi: assets & liabilities 28
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.